soilDBdata
soilDBdata exists so soilDB's tests can run without a NASIS connection.
A side-by-side editorial comparison of forecasting and medsim — release velocity, themes, recent moves, and the top alternatives to consider.
HIDDA.forecasting is a book chapter's reproducibility artifact, not a package under development.
HIDDA.forecasting accompanies a book chapter on forecasting infectious disease counts; its vignettes reproduce the results presented there using arima, prophet, glarma, hhh4contacts and scoringRules. The 1.0.0 release states this outright — it is the version used for the chapter, pinned to CRAN package versions as of July 2018. Every release since has been a vignette rebuild against newer R and dependency versions.
medsim is turning simulation runs into auditable artifacts, not just fast ones.
medsim is a young Monte Carlo harness for mediation-analysis simulation studies, first tagged in May 2026 and already at 0.5.1. The last two releases moved the package's center of gravity from running simulations to proving a run is trustworthy: chunk provenance headers, a single-SHA assertion across chunks, and a pilot-subset positive control. The statistical work sits in the missing-data line added in 0.2.0 — Fleishman non-normal generators, rate-calibrated MCAR/MAR/MNAR amputation, and a validated D4-stacked MBCO estimator.
HIDDA.forecasting accompanies a book chapter on forecasting infectious disease counts; its vignettes reproduce the results presented there using arima, prophet, glarma, hhh4contacts and scoringRules. The 1.0.0 release states this outright — it is the version used for the chapter, pinned to CRAN package versions as of July 2018. Every release since has been a vignette rebuild against newer R and dependency versions.
The release pattern is maintenance on an eight-year cadence dictated entirely by the surrounding ecosystem: 1.1.1 rebuilt under R 4.0.4, 1.1.2 under R 4.3.2, 1.1.3 under R 4.6.1, each reporting whether the numbers moved. They mostly have not — the recurring note is minor numerical differences confined to the prophet forecasts in vignette('CHILI_prophet'). The only substantive change in the visible history is 1.1.0's methodological tidy-up of the scoring comparisons.
Nothing in these entries points to new functionality; the next release is most likely another vignette rebuild whenever a dependency change or a CRAN check failure forces one.
medsim is a young Monte Carlo harness for mediation-analysis simulation studies, first tagged in May 2026 and already at 0.5.1. The last two releases moved the package's center of gravity from running simulations to proving a run is trustworthy: chunk provenance headers, a single-SHA assertion across chunks, and a pilot-subset positive control. The statistical work sits in the missing-data line added in 0.2.0 — Fleishman non-normal generators, rate-calibrated MCAR/MAR/MNAR amputation, and a validated D4-stacked MBCO estimator.
The arc is toward defensible HPC runs: each 0.5.x gate closes a way a cluster job could silently produce wrong output, and 0.5.1 extends the same suspicion to the estimator itself by exposing the branch disagreement the standard ARIV averages away. Releases are cadenced against discovered defects rather than a roadmap — 0.5.0 cites seven findings from a pre-integration review, and 0.5.1 cites an adversarial review of 0.5.0. The audit surface is widening faster than the method surface.
The collapse-audit exclusion list has now been patched twice for method-specific diagnostic columns, so the next likely move is a contract letting methods declare their own discrete fields instead of medsim naming them centrally.
Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either forecasting or medsim.
soilDBdata exists so soilDB's tests can run without a NASIS connection.
collinear has broken its API twice to stop making the user pick thresholds.
nert put fourteen TERN datasets behind one dispatcher and called it stable.
scTypeEval judges single-cell annotations without needing a ground truth to judge them against.
medrobust made its partial-identification bounds usable by giving them confidence intervals.
probmed went from one probabilistic effect size to a family of them in sixteen days.
See all forecasting alternatives → · See all medsim alternatives →
Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.
Both compete on the same themes — reproducibility, r package — within Analytics. medsim is currently shipping more aggressively (velocity 6.3 vs 0.0), with 1 editorial sparks in the last 30 days against 0. See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.
Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. medsim is currently shipping more aggressively (velocity 6.3 vs 0.0), with 1 editorial sparks in the last 30 days against 0. For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.
Top forecasting alternatives in Analytics are ranked by recent ship velocity. Browse the "forecasting alternatives" section above for the current picks, or visit /alternatives/forecasting for the full list with editorial commentary on each.
Top medsim alternatives in Analytics are ranked by recent ship velocity. Browse the "medsim alternatives" section above for the current picks, or visit /alternatives/medsim for the full list with editorial commentary on each.